BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
SNCA
,
Fatty acid metabolic process
,
Hepatitis
,
Neuron
,
Laryngoscope
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cellular response to actinomycin D
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thymus gland
Heart
Fallopian tube
Ovary
Frontal lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Immortalized human lung small airway epithelial cells siRNA transfected
Melanoma A375 cells with p53, CDT1 or BRCA1 knockdown and daunorubicin, nutlin or MLN4924 treatment
Trp53 in K-Ras lung tumor cells and MEF DNA damage response after p53, lincRNA-p21, or hnRNP-K
Malignant pleural mesothelioma cells and xenografts - mithramycin treated or overexpressing P53
Muscle stem cells from healthy uninjured, injured and mdx/mTRG2 mice with p53 wildtype or knockout
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for cellular response to actinomycin D
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ